Halothane inhibition of recombinant cardiac L-type Ca2+ channels expressed in HEK-293 cells

Kevin J Gingrich1, Son Tran, Igor M Nikonorov

  • 1Department of Anesthesiology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. kevin.gingrich@med.nyu.edu

Anesthesiology
|November 25, 2005
PubMed

Insights

Volatile anesthetics like halothane inhibit cardiac L-type calcium channels. The alpha2/delta1 subunit significantly enhances this effect by altering channel states at resting membrane potential.

Area of Science:

  • Cardiology
  • Pharmacology
  • Molecular Biology

Background:

  • Volatile anesthetics depress cardiac contractility by inhibiting cardiac L-type calcium channels.
  • Understanding the role of voltage-dependent inactivation is crucial for anesthetic drug development.

Purpose of the Study:

  • To investigate the impact of the alpha2/delta1 subunit on halothane's inhibition of cardiac L-type calcium channels.
  • To elucidate the mechanisms underlying halothane's effects on channel function and transmembrane charge transfer.

Main Methods:

  • Recombinant cardiac L-type calcium channel subunits (alpha1Cbeta2a and alpha1Cbeta2aalpha2/delta1) were expressed in HEK-293 cells.
  • Patch clamp electrophysiology was used to record macroscopic barium currents and assess halothane's effects.
  • Cells were identified for patch-clamp recording via fluorescence microscopy.

Main Results:

  • Halothane inhibited peak current (I(peak)) and enhanced inactivation in a concentration-dependent manner for both channel types.
  • Coexpression of alpha2/delta1 significantly increased halothane's potency for inhibiting I(peak) and inactivation.
  • Halothane reduced transmembrane charge transfer primarily through I(peak) depression, not enhanced inactivation.

Conclusions:

  • Phenotypic features conferred by the alpha2/delta1 subunit are critical for halothane's inhibition of cardiac L-type calcium channels.
  • Halothane's primary mechanism involves depression of I(peak) due to transitions to nonactivatable states at resting potentials.
  • The study highlights the importance of resting membrane potential states in halothane's action, discounting the role of inactivation in charge transfer reduction.
Abstract

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...